Tatva Chintan Pharma Chem Ltd. Closes Trading Window Ahead of Financial Results Announcement
Vadodara, Gujarat, March 24, 2026 – Tatva Chintan Pharma Chem Ltd. announced today the closure of its trading window for designated individuals and their immediate relatives. The closure, mandated by SEBI (Prohibition of Insider Trading) Regulations, 2015, commenced on Wednesday, April 1, 2026, and will remain in effect until 48 hours following the release of the company’s audited financial results for the quarter and fiscal year ending March 31, 2026. The move is standard practice to prevent potential insider trading activities.Ishwar Nayi, Company Secretary and Compliance Officer, confirmed the measure in a communication to the Bombay Stock Exchange (BSE) under Scrip Code: 543321 and the National Stock Exchange of India Limited (NSE) under Scrip Symbol: TATVA.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.